Institutional members access full text with Ovid®

Share this article on:

The role of activists in access to HIV and tuberculosis treatment and prevention

Geffen, Nathan

Current Opinion in HIV and AIDS: July 2017 - Volume 12 - Issue 4 - p 398–402
doi: 10.1097/COH.0000000000000381
TOWARDS A UNIVERSAL ANTIRETROVIRAL REGIMEN: Edited by Charles W. Flexner, Willem D.F. Venter, and Polly Clayden

Purpose of review We describe the role of activism in improving access to quality HIV treatment.

Recent findings In many countries, AIDS activists have campaigned for improved access to HIV treatment and prevention interventions. Studying medicine, epidemiology and law, and developing expertise in these fields, has been crucial to the success of these campaigns. Also important has been the building of alliances by activists with clinicians, nurses, scientists, and public health policy experts, persuading them of the importance of these campaigns. This article describes examples of campaigns in several middle and low-income countries, showing how activists, by becoming familiar with HIV science, have helped make antiretrovirals available to millions of people across the world. HIV activists have also been drawn into, and driven, broader struggles for health social justice, such as campaigns for new tuberculosis and hepatitis C.

Summary Scientists and activists need to continue to work together to improve access to treatment. But to be effective, a critical mass of activists must develop expertise in HIV science and the law.

Centre for Social Science Research, University of Cape Town, Rondebosch, Cape Town, South Africa

Correspondence to Nathan Geffen, Centre for Social Science Research, University of Cape Town, Rondebosch, Cape Town, South Africa, 7700. Tel: +27 21 650 9111; e-mail: nathangeffen@gmail.com

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.